Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Cigna Corporation (CI) Share Price
Media coverage about Cigna Corporation (NYSE:CI) has been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cigna Corporation earned a news sentiment score of 0.17 on Accern’s scale. Accern also gave media coverage about the health services provider an impact score of 46.2069994242434 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Here are some of the news headlines that may have effected Accern’s analysis:
- Jason D. Sadler Sells 37,756 Shares of Cigna Corporation (NYSE:CI) Stock (americanbankingnews.com)
- Cigna Corporation (CI) – Deutsche Bank Maintains Rating And Raises Price Target – Modern Readers (modernreaders.com)
- Sentry Investments Corp. Sells A Little More Cigna Corporation (CI) Stock – Modern Readers (modernreaders.com)
- Cigna Roots for the Home Team with Sponsorship of the Hartford … – Business Wire (press release) (businesswire.com)
- Cigna Roots for the Home Team with Sponsorship of the Hartford Yard Goats (finance.yahoo.com)
CI has been the subject of a number of recent analyst reports. Morgan Stanley lifted their target price on shares of Cigna Corporation from $184.00 to $188.00 and gave the stock an “overweight” rating in a research note on Monday. Deutsche Bank AG lifted their target price on shares of Cigna Corporation from $180.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday. CIBC lifted their target price on shares of Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, June 15th. Wells Fargo & Company reiterated a “market perform” rating and issued a $174.00 target price (up from $163.00) on shares of Cigna Corporation in a research note on Monday, June 19th. Finally, Oppenheimer Holdings, Inc. lifted their target price on shares of Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, June 15th. Three research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. Cigna Corporation presently has an average rating of “Buy” and a consensus target price of $180.06.
Cigna Corporation (CI) traded up 1.39% during trading on Wednesday, hitting $178.08. 1,508,798 shares of the company traded hands. The company’s 50-day moving average is $171.37 and its 200 day moving average is $158.04. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $178.50. The firm has a market cap of $45.59 billion, a price-to-earnings ratio of 23.78 and a beta of 0.46.
Cigna Corporation (NYSE:CI) last announced its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 7.46% and a return on equity of 17.40%. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the firm posted $1.98 earnings per share. On average, equities analysts anticipate that Cigna Corporation will post $10.00 earnings per share for the current year.
In related news, VP Mary T. Hoeltzel sold 500 shares of the stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total transaction of $83,350.00. Following the completion of the sale, the vice president now directly owns 2,449 shares of the company’s stock, valued at $408,248.30. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO David Cordani sold 153,168 shares of the stock in a transaction on Monday, June 19th. The stock was sold at an average price of $170.20, for a total value of $26,069,193.60. Following the sale, the chief executive officer now directly owns 421,162 shares of the company’s stock, valued at $71,681,772.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 257,314 shares of company stock valued at $43,786,762. Corporate insiders own 1.30% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Cigna Corporation (CI) Share Price” was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.watchlistnews.com/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-cigna-corporation-ci-share-price/1466723.html.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.